X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2900) 2900
Publication (204) 204
Book Review (91) 91
Book Chapter (12) 12
Magazine Article (8) 8
Book / eBook (3) 3
Conference Proceeding (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rheumatoid arthritis (1891) 1891
humans (1804) 1804
modifying antirheumatic drugs (1725) 1725
rheumatology (1658) 1658
index medicus (1530) 1530
arthritis, rheumatoid - drug therapy (1286) 1286
antirheumatic agents - therapeutic use (1078) 1078
female (936) 936
male (904) 904
middle aged (818) 818
methotrexate (808) 808
double-blind (716) 716
treatment outcome (632) 632
adult (622) 622
arthritis (586) 586
aged (568) 568
rheumatoid factor (482) 482
disease-modifying antirheumatic drugs (419) 419
therapy (388) 388
antirheumatic agents - adverse effects (368) 368
drug therapy (361) 361
pharmacology & pharmacy (339) 339
drug therapy, combination (329) 329
methotrexate - therapeutic use (316) 316
care and treatment (312) 312
severity of illness index (309) 309
antirheumatic agents (308) 308
medicine & public health (303) 303
disease (301) 301
antirheumatic agents - administration & dosage (291) 291
disease-activity (291) 291
etanercept (284) 284
efficacy (281) 281
arthritis, rheumatoid - diagnosis (280) 280
rheumatoid-arthritis (278) 278
inadequate response (272) 272
recommendations (269) 269
risk factors (260) 260
tumor necrosis factor-alpha - antagonists & inhibitors (259) 259
combination therapy (253) 253
medicine, general & internal (245) 245
infliximab (243) 243
placebo-controlled trial (229) 229
immunology (226) 226
analysis (222) 222
safety (222) 222
internal medicine (218) 218
management (216) 216
time factors (216) 216
eular recommendations (215) 215
remission (208) 208
abridged index medicus (191) 191
adalimumab (189) 189
patients (189) 189
american-college (183) 183
disease progression (173) 173
retrospective studies (169) 169
clinical trials (160) 160
research (160) 160
biologics (157) 157
disease modifying antirheumatic drugs (155) 155
inflammation (155) 155
biological products - therapeutic use (153) 153
medical research (151) 151
arthritis, rheumatoid - physiopathology (147) 147
drugs (147) 147
risk (146) 146
tocilizumab (146) 146
animals (145) 145
cohort studies (145) 145
combination (145) 145
antibodies, monoclonal - therapeutic use (142) 142
arthritis, rheumatoid - epidemiology (142) 142
tumor-necrosis-factor (141) 141
remission induction (140) 140
health aspects (138) 138
arthritis, rheumatoid - immunology (137) 137
methotrexate - administration & dosage (136) 136
studies (135) 135
dosage and administration (134) 134
randomized controlled-trial (133) 133
medicine, experimental (131) 131
radiographic progression (131) 131
antitumor necrosis factor (130) 130
follow-up (130) 130
quality-of-life (129) 129
sulfasalazine (129) 129
musculoskeletal diseases (128) 128
tumor necrosis factor-tnf (127) 127
aged, 80 and over (126) 126
placebo (125) 125
disease-modifying anti-rheumatic drugs (123) 123
treatment (123) 123
follow-up studies (119) 119
low-dose methotrexate (119) 119
methotrexate - adverse effects (119) 119
monoclonal-antibody (118) 118
prospective studies (118) 118
psoriatic arthritis (118) 118
leflunomide (117) 117
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2689) 2689
German (122) 122
Russian (33) 33
French (19) 19
Japanese (19) 19
Spanish (15) 15
Polish (10) 10
Czech (3) 3
Portuguese (3) 3
Korean (2) 2
Serbian (2) 2
Slovak (2) 2
Chinese (1) 1
Hungarian (1) 1
Italian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Inflammation & allergy drug targets, ISSN 1871-5281, 2014, Volume 13, Issue 4, pp. 249 - 261
Journal Article
Journal Article
Journal Article
Reumatologia/Rheumatology, ISSN 0034-6233, 2019, Volume 57, Issue 4, pp. 214 - 220
Biological disease-modifying antirheumatic drugs target specific components of the immune response related to pathogenesis of autoimmune and inflammatory... 
adverse effects | biologic agents | Review Paper | biological disease-modifying antirheumatic drugs
Journal Article
Arthritis Care & Research, ISSN 2151-464X, 06/2018, Volume 70, Issue 6, pp. 834 - 841
Journal Article
Journal Article
Internal Medicine, ISSN 0918-2918, 2019
Objectives The present study was performed with the aim of analyzing the biological disease-modifying antirheumatic drug (bDMARD)-free (Bio-free) condition of... 
methotrexate | conventional synthetic disease-modifying antirheumatic drugs | rheumatoid arthritis | biologics free condition | adalimumab
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 11/2012, Volume 39, Issue 11, pp. 2088 - 2097
Journal Article